Role of miRNA-mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy

Fernando Bonet1, Oscar Campuzano2,3,4, José Córdoba-Caballero1,5

  • 1Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 Cádiz, Spain.

Biomedicines
|August 29, 2024
PubMed

Insights

This study reveals novel microRNAs (miRNAs) involved in arrhythmogenic cardiomyopathy (ACM) pathogenesis. These findings offer potential new therapeutic targets for this inherited heart condition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Disease Pathogenesis

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is an inherited heart condition causing ventricular arrhythmias and sudden cardiac death.
  • Genetic variants in desmosome genes are primary causes, but molecular mechanisms remain unclear.
  • Signaling pathways like Wnt/ß-catenin and TGF-β are implicated in ACM progression.

Purpose of the Study:

  • To investigate the molecular pathophysiology of arrhythmogenic cardiomyopathy using transcriptomic analysis.
  • To identify novel differentially expressed genes and microRNAs (miRNAs) in ACM hearts.
  • To explore miRNA-mRNA interactions in ACM pathogenesis.

Main Methods:

  • Analysis of mRNA and small RNA sequencing data from autopsied human hearts (ACM vs. healthy).
  • Differential gene and miRNA expression analysis.
  • Functional enrichment analysis and miRNA-mRNA interactome analysis.

Main Results:

  • Identified 697 differentially expressed genes and 8 differentially expressed miRNAs in ACM hearts.
  • Functional enrichment highlighted pathways related to mitochondrial respiration, oxidative stress, apoptosis, inflammation, and extracellular matrix.
  • Discovered 11 negatively correlated miRNA-target pairs relevant to ACM.

Conclusions:

  • Novel ACM-associated miRNAs with regulatory roles in disease pathogenesis were identified.
  • These miRNAs represent potential key targets for future therapeutic strategies in arrhythmogenic cardiomyopathy.
  • Understanding these molecular players advances knowledge of ACM pathophysiology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
901
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Nucleic Acid Structure01:25

Nucleic Acid Structure

The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
6.1K
Nucleic Acids02:43

Nucleic Acids

Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
44.0K